Madrigal Pharmaceuticals (MDGL) PT Raised to $193 at Canaccord Genuity, Following Earnings
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $517.22 +1.90%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $193.00 (from $179.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yum! Brands (YUM) PT Lowered to $180 at Argus
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
- Kweichow Moutai Co Ltd (600519:CH) PT Lowered to RMB1,400 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Earnings, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
